San Francisco Sentry Investment Group’s GALENA BIOPHARMA INC COM RXII Stock Holding History

San Francisco Sentry Investment Group’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-12,150	Closed	-$18K	–	170
2015 Q4	$18K	Buy	12,150 +800	+7%	+$1.19K	0.01%	154
2015 Q3	$18K	Hold	11,350	–	–	0.01%	148
2015 Q2	$19K	Sell	11,350 -2,500	-18%	-$4.18K	0.01%	152
2015 Q1	$19K	Buy	13,850 +500	+4%	+$686	0.01%	148
2014 Q4	$20K	Hold	13,350	–	–	0.01%	154
2014 Q3	$28K	Buy	13,350 +6,200	+87%	+$13K	0.01%	367
2014 Q2	$22K	Buy	7,150 +3,700	+107%	+$11.4K	0.01%	402
2014 Q1	$9K	Buy	3,450 +450	+15%	+$1.17K	﹤0.01%	544
2013 Q4	$15K	Buy	+3,000	New	+$15K	0.01%	455
2013 Q3	–	Sell	-1,500	Closed	-$3K	–	727
2013 Q2	$3K	Buy	+1,500	New	+$3K	﹤0.01%	607

Other funds holding RXII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 28.54% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

San Francisco Sentry Investment Group's RXII Position: Q1 2016 in Review

San Francisco Sentry Investment Group sold out of GALENA BIOPHARMA INC COM (RXII) in Q1 2016, closing a stake of 12,150 shares — an estimated $18K sold.

San Francisco Sentry Investment Group first reported a position in RXII in Q2 2013 and held it in 10 quarters. The position peaked at $28K in Q3 2014. 71 funds tracked by Wall St. Rank hold RXII as of Q1 2016.

San Francisco Sentry Investment Group reported no remaining GALENA BIOPHARMA INC COM position as of Q1 2016 after selling out during the quarter.
San Francisco Sentry Investment Group sold 12,150 GALENA BIOPHARMA INC COM shares in Q1 2016, an estimated $18K.
San Francisco Sentry Investment Group first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 10 quarters.
San Francisco Sentry Investment Group's GALENA BIOPHARMA INC COM position peaked at $28K in Q3 2014.
71 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q1 2016.

Based on San Francisco Sentry Investment Group's 13F filing for Q1 2016, filed 29 Apr 2016.